Cullinan Oncology LLC

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$6.85-$21.01
Market Cap
$452.6M
Shares Short
5M

Financials

See more
Revenue (12 Mos)
$0
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$18.9M
Diluted EPS
-$2.77

News

See more

Yahoo Finance • 15 days ago

InvestingPro's Fair Value model predicted CGEM's significant price correction

Yahoo Finance • 17 days ago

Cullinan Oncology stock rating reiterated at Buy by Clear Street

Yahoo Finance • 2 months ago

Cullinan Therapeutics, Taiho Pharmaceutical, and Taiho Oncology to Present Positive Results from Pivotal Phase 2b REZILIENT1 Trial of Zipalertinib at ASCO 2025

Yahoo Finance • 3 months ago

Cullinan Therapeutics to Present Results from REZILIENT1, a Phase 1/2 Trial of Zipalertinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations Who Have Received Prior Therapy, at ASCO 2025

About

CEO
Mr. Nadim Ahmed
Address
One Main Street, Cambridge, MA, United States, 02142
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
111